{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T23:38:54Z","timestamp":1781653134639,"version":"3.54.5"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejinme.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.ejim.2023.01.018","type":"journal-article","created":{"date-parts":[[2023,1,30]],"date-time":"2023-01-30T08:18:19Z","timestamp":1675066699000},"page":"35-40","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["The efficacy and safety of tacrolimus in patients with dermatomyositis\/polymyositis: A meta-analysis and systematic review"],"prefix":"10.1016","volume":"110","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2890-9382","authenticated-orcid":false,"given":"Jiafen","family":"Liao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofei","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7143-0089","authenticated-orcid":false,"given":"Jia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ejim.2023.01.018_bib0001","doi-asserted-by":"crossref","first-page":"R22","DOI":"10.1186\/ar3704","article-title":"Predictors of survival in a cohort of patients with polymyositis and dermatomyositis: effect of corticosteroids, methotrexate and azathioprine","volume":"14","author":"Schiopu","year":"2012","journal-title":"Arthritis Res Ther"},{"issue":"2","key":"10.1016\/j.ejim.2023.01.018_bib0002","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1007\/s10067-005-1164-z","article-title":"Prognosis and mortality of polymyositis and dermatomyositis patients","volume":"25","author":"Airio","year":"2006","journal-title":"Clin Rheumatol"},{"issue":"1","key":"10.1016\/j.ejim.2023.01.018_bib0003","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1136\/annrheumdis-2020-eular.4048","article-title":"AB0627\u2005prognosis and mortality of dermatomyositis and polymyositis patients with malignancy","volume":"79","author":"Yang","year":"2020","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.ejim.2023.01.018_bib0004","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s00408-016-9896-x","article-title":"Assessment of mortality in autoimmune myositis with and without associated interstitial lung disease","volume":"194","author":"Johnson","year":"2016","journal-title":"Lung"},{"issue":"5","key":"10.1016\/j.ejim.2023.01.018_bib0005","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1093\/rheumatology\/keac115","article-title":"British Society for Rheumatology guideline on management of paediatric, adolescent and adult patients with idiopathic inflammatory myopathy","volume":"61","author":"Oldroyd","year":"2022","journal-title":"Rheumatology"},{"issue":"8","key":"10.1016\/j.ejim.2023.01.018_bib0006","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1002\/art.21240","article-title":"Treatment of antisynthetase-associated interstitial lung disease with tacrolimus","volume":"52","author":"Wilkes","year":"2005","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.ejim.2023.01.018_bib0007","article-title":"Prednisolone and tacrolimus versus prednisolone and cyclosporin A to treat polymyositis\/dermatomyositis-associated ILD: a randomized, open-label trial","author":"Fujisawa","year":"2020","journal-title":"Respirology"},{"issue":"1","key":"10.1016\/j.ejim.2023.01.018_bib0008","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/14397595.2018.1521185","article-title":"Treatment consensus for management of polymyositis and dermatomyositis among rheumatologists, neurologists and dermatologists","volume":"29","author":"Kohsaka","year":"2019","journal-title":"Mod Rheumatol"},{"issue":"7","key":"10.1016\/j.ejim.2023.01.018_bib0009","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1056\/NEJM197502132920706","article-title":"Polymyositis and dermatomyositis (first of two parts)","volume":"292","author":"Bohan","year":"1975","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.ejim.2023.01.018_bib0010","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1136\/annrheumdis-2017-211468","article-title":"2017 European league against rheumatism\/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups","volume":"76","author":"Lundberg","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.ejim.2023.01.018_bib0011","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0733-8635(02)00021-9","article-title":"Dermatomyositis: an overview of recent progress with emphasis on dermatologic aspects","volume":"20","author":"Sontheimer","year":"2002","journal-title":"Dermatol Clin"},{"issue":"7","key":"10.1016\/j.ejim.2023.01.018_bib0012","doi-asserted-by":"crossref","first-page":"707","DOI":"10.3899\/jrheum.210322","article-title":"Tacrolimus in patients with interstitial pneumonia associated with polymyositis or dermatomyositis: interim report of postmarketing surveillance in Japan","volume":"49","author":"Kuwana","year":"2022","journal-title":"J Rheumatol"},{"issue":"3","key":"10.1016\/j.ejim.2023.01.018_bib0013","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1002\/art.41105","volume":"72","author":"Tsuji","year":"2020","journal-title":"Arthritis Rheumatol"},{"issue":"5","key":"10.1016\/j.ejim.2023.01.018_bib0014","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1093\/rheumatology\/kez394","article-title":"Impact of adding tacrolimus to initial treatment of interstitial pneumonitis in polymyositis\/dermatomyositis: a single-arm clinical trial","volume":"59","author":"Takada","year":"2020","journal-title":"Rheumatology"},{"issue":"6","key":"10.1016\/j.ejim.2023.01.018_bib0015","doi-asserted-by":"crossref","first-page":"888","DOI":"10.3109\/14397595.2015.1029239","article-title":"Corticosteroid-sparing effect of tacrolimus in the initial treatment of dermatomyositis and polymyositis","volume":"25","author":"Yokoyama","year":"2015","journal-title":"Mod Rheumatol"},{"issue":"10","key":"10.1016\/j.ejim.2023.01.018_bib0016","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1007\/s10067-012-2044-y","article-title":"Effects of tacrolimus on dermatomyositis and polymyositis: a prospective, open, non-randomized study of nine patients and a review of the literature","volume":"31","author":"Matsubara","year":"2012","journal-title":"Clin Rheumatol"},{"issue":"12","key":"10.1016\/j.ejim.2023.01.018_bib0017","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1111\/1756-185X.12931","article-title":"Advantage of administering tacrolimus for improving prognosis of patients with polymyositis and dermatomyositis","volume":"19","author":"Ueno","year":"2016","journal-title":"Int J Rheum Dis"},{"issue":"1","key":"10.1016\/j.ejim.2023.01.018_bib0018","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1093\/rheumatology\/keu166","article-title":"The efficacy of tacrolimus in patients with interstitial lung diseases complicated with polymyositis or dermatomyositis","volume":"54","author":"Kurita","year":"2014","journal-title":"Rheumatology"},{"issue":"1","key":"10.1016\/j.ejim.2023.01.018_bib0019","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s42358-019-0048-x","article-title":"Guidelines of the Brazilian Society of Rheumatology for the treatment of systemic autoimmune myopathies","volume":"59","author":"de Souza","year":"2019","journal-title":"Adv Rheumatol"},{"issue":"3","key":"10.1016\/j.ejim.2023.01.018_bib0020","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1046\/j.1365-2249.2002.01933.x","article-title":"Activation of pulmonary T cells in corticosteroid-resistant and -sensitive interstitial pneumonitis in dermatomyositis\/polymyositis","volume":"129","author":"Kurasawa","year":"2002","journal-title":"Clin Exp Immunol"},{"issue":"12","key":"10.1016\/j.ejim.2023.01.018_bib0021","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1007\/s10067-015-3065-0","article-title":"The efficacy of tacrolimus in patients with refractory dermatomyositis\/polymyositis: a systematic review","volume":"34","author":"Ge","year":"2015","journal-title":"Clin Rheumatol"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620523000249?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620523000249?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T09:38:18Z","timestamp":1760607498000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620523000249"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":21,"alternative-id":["S0953620523000249"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2023.01.018","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The efficacy and safety of tacrolimus in patients with dermatomyositis\/polymyositis: A meta-analysis and systematic review","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2023.01.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}